These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

518 related items for PubMed ID: 9496338

  • 1. Timing of onset of contraceptive effectiveness in Depo-Provera users: Part I. Changes in cervical mucus.
    Petta CA, Faundes A, Dunson TR, Ramos M, DeLucio M, Faundes D, Bahamondes L.
    Fertil Steril; 1998 Feb; 69(2):252-7. PubMed ID: 9496338
    [Abstract] [Full Text] [Related]

  • 2. Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus.
    Dunson TR, Blumenthal PD, Alvarez F, Brache V, Cochon L, Dalberth B, Glover L, Remsburg R, Vu K, Katz D.
    Fertil Steril; 1998 Feb; 69(2):258-66. PubMed ID: 9496339
    [Abstract] [Full Text] [Related]

  • 3. Timing of onset of contraceptive effectiveness in Depo-Provera users. II. Effects on ovarian function.
    Petta CA, Faúndes A, Dunson TR, Ramos M, DeLucio M, Faúndes D, Bahamondes L.
    Fertil Steril; 1998 Nov; 70(5):817-20. PubMed ID: 9806559
    [Abstract] [Full Text] [Related]

  • 4. Temporal relationship between Uniplant insertion and changes in cervical mucus.
    Barbosa IC, Coutinho E, Hirsch C, Ladipo OA, Olsson SE, Ulmsten U.
    Contraception; 1996 Oct; 54(4):213-7. PubMed ID: 8922874
    [Abstract] [Full Text] [Related]

  • 5. Forearm bone density in users of Depo-Provera as a contraceptive method.
    Bahamondes L, Perrotti M, Castro S, Faúndes D, Petta C, Bedone A.
    Fertil Steril; 1999 May; 71(5):849-52. PubMed ID: 10231044
    [Abstract] [Full Text] [Related]

  • 6. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R, Hales HA, Stevenson K, Hatasaka HH, Poulson AM, Jones KP, Peterson CM.
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [Abstract] [Full Text] [Related]

  • 7. Delayed first injection of the once-a-month injectable contraceptive containing 25 mg medroxyprogesterone acetate and 5 mg estradiol-cypionate: effects on cervical mucus.
    Petta CA, Hays M, Brache V, Massai R, Hua Y, Alvarez-Sánchez F, Salvatierra A, d'Arcangues C, Cook LA, Bahamondes L.
    Contraception; 2001 Dec; 64(6):363-8. PubMed ID: 11834235
    [Abstract] [Full Text] [Related]

  • 8. Depot medroxyprogesterone acetate pioneers. A retrospective study at a North Carolina Health Department.
    Potter LS, Dalberth BT, Cañamar R, Betz M.
    Contraception; 1997 Nov; 56(5):305-12. PubMed ID: 9437559
    [Abstract] [Full Text] [Related]

  • 9. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA, Blair JM, Mahan JD, Zibners L, Naumovski Z.
    J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
    [Abstract] [Full Text] [Related]

  • 10. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
    Polaneczky M, Liblanc M.
    J Adolesc Health; 1998 Aug; 23(2):81-8. PubMed ID: 9714170
    [Abstract] [Full Text] [Related]

  • 11. Depo Provera: a profile of current users.
    Jarman H, Kovacs GT, Westcott M.
    Aust N Z J Obstet Gynaecol; 1990 Feb; 30(1):74-6. PubMed ID: 2140675
    [Abstract] [Full Text] [Related]

  • 12. Bone density among long-term users of medroxyprogesterone acetate as a contraceptive.
    Paiva LC, Pinto-Neto AM, Faundes A.
    Contraception; 1998 Dec; 58(6):351-5. PubMed ID: 10095971
    [Abstract] [Full Text] [Related]

  • 13. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives.
    Moore LL, Valuck R, McDougall C, Fink W.
    Contraception; 1995 Oct; 52(4):215-9. PubMed ID: 8605778
    [Abstract] [Full Text] [Related]

  • 14. The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy.
    Mauck CK, Callahan MM, Baker J, Arbogast K, Veazey R, Stock R, Pan Z, Morrison CS, Chen-Mok M, Archer DF, Gabelnick HL.
    Contraception; 1999 Jul; 60(1):15-24. PubMed ID: 10549448
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of visible disruption of cervical epithelium and cervical ectopy in African women using Depo-Provera.
    Kuhn L, Denny L, Pollack AE, Wright TC.
    Contraception; 1999 Jun; 59(6):363-7. PubMed ID: 10518230
    [Abstract] [Full Text] [Related]

  • 16. Effects of a single contraceptive Silastic implant containing nomegestrol acetate on ovarian function and cervical mucus production during 2 years.
    Barbosa I, Coutinho E, Hirsch C, Ladipo O, Olsson SE, Ulmsten U.
    Fertil Steril; 1996 Apr; 65(4):724-9. PubMed ID: 8654629
    [Abstract] [Full Text] [Related]

  • 17. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): assessment of return of ovulation after three monthly injections in surgically sterile women.
    Rahimy MH, Ryan KK.
    Contraception; 1999 Oct; 60(4):189-200. PubMed ID: 10640165
    [Abstract] [Full Text] [Related]

  • 18. Depressive symptoms and Depo-Provera.
    Westhoff C, Truman C, Kalmuss D, Cushman L, Davidson A, Rulin M, Heartwell S.
    Contraception; 1998 Apr; 57(4):237-40. PubMed ID: 9649914
    [Abstract] [Full Text] [Related]

  • 19. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): steady-state pharmacokinetics of MPA and E2 in surgically sterile women.
    Rahimy MH, Ryan KK, Hopkins NK.
    Contraception; 1999 Oct; 60(4):209-14. PubMed ID: 10640167
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic study of different doses of Depo Provera.
    Fotherby K, Koetsawang S, Mathrubutham M.
    Contraception; 1980 Nov; 22(5):527-36. PubMed ID: 6451351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.